STOCK TITAN

Lifevantage director Raymond B. Greer gets 17,888 shares

The award is scheduled to vest in one installment on November 5, 2027, subject to the director's continuous service through that date.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Lifevantage Corp (LFVN) director Raymond B. Greer received an award of 17,888 common shares on November 5, 2026. His reported direct holdings after the award were 130,707 shares. The award was made under the issuer’s outside director compensation program and is scheduled to vest in one installment on November 5, 2027, subject to his continuous service through that date. The reported $5.87 per-share figure equals the weighted average closing price for the ten trading days ending the day before the grant.

Insider Greer Raymond B
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1, F2 17,888 $5.87 $105K
Holdings After Transaction: Common Stock — 130,707 shares (Direct)
Footnotes (2)
  1. F1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 5, 2027, subject to the reporting person's continuous service to the issuer through such date.
  2. F2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.
Awarded common shares 17,888 shares Granted November 5, 2026
Direct shares following award 130,707 shares Reported after the November 5, 2026 transaction
Reported price-column figure $5.87 per share Equals the weighted average closing price for the ten trading days ending the day before the grant
outside director compensation program financial
"pursuant to the issuer's outside director compensation program"
weighted average closing price financial
"equal to the weighted average closing price of the issuer's common stock"
continuous service technical
"subject to the reporting person's continuous service to the issuer through such date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did LFVN director Raymond B. Greer receive?

Raymond B. Greer, a director, was granted 17,888 shares of Lifevantage common stock on November 5, 2026. His reported direct holdings after the grant were 130,707 shares.

When will Raymond B. Greer's LFVN share award vest?

The award is scheduled to vest in one installment on November 5, 2027, subject to Raymond B. Greer's continuous service to the issuer through that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Greer Raymond B

(Last)(First)(Middle)
3300 TRIUMPH BLVD, SUITE 700

(Street)
LEHI UTAH 84043

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Lifevantage Corp [ LFVN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/05/2026A17,888(1)A$5.87(2)130,707D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 5, 2027, subject to the reporting person's continuous service to the issuer through such date.
2. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant.
/s/ Raymond B. Greer11/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading